State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).

Autor: Rodríguez-Jiménez P; Hospital Universitario de la Princesa, Madrid, Spain., Jimenez YD; Hospital Universitario de la Princesa, Madrid, Spain.; Hospital Universitario Quirón Salud, Madrid, Spain., Reolid A; Hospital Universitario de la Princesa, Madrid, Spain., Sanmartın-Jimenez O; Instituto Valenciano de Oncología, Valencia, Spain., Garces JR; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Centro Médico Teknon, Barcelona, Spain., Rodríguez-Prieto MA; Complejo Asistencial Universitario de León, León, Spain., Medrano RM; Hospital Universitario Fundación Alcorcón, Madrid, Spain., Vilarrasa E; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Centro Médico Teknon, Barcelona, Spain., de Eusebio-Murillo E; Complejo Hospitalario Universitario de Guadalajara, Guadalajara, Spain., Redondo P; Clínica Universidad de Navarra, Pamplona, Spain., Ciudad-Blanco C; Hospital La Zarzuela, Madrid, Spain.; H Gregorio Marañón, Madrid, Spain., Morales-Gordillo V; Hospital Universitario Quirón Salud, Madrid, Spain., Toll-Abelló A; Hospital del Mar, Barcelona, Spain., Artola-Igarza JL; Hospital Galdakao, Galdakao, Spain., Pacheco MLA; Hospital La Paz, Madrid, Spain., Markixana IA; Hospital Universitario de Cruces, Barakaldo, Spain., Fernández RS; H Gregorio Marañón, Madrid, Spain., Rubio AA; Hospital Manises, Valencia, Spain., Vázquez-Veiga H; Complexo Hospitalario Universitario de Santiago, Santiago Compostela, Spain., Flórez-Menéndez A; Complejo Universitario Hospitalario Pontevedra, Pontevedra, Spain., de la Cueva Dobao P; Hospital Infanta Leonor, Madrid, Spain., Botella-Estrada R; Hospital Universitario La Fe, Valencia, Spain., Garcia-Bracamonte B; Hospital Universitario Doce de Octubre, Madrid, Spain., Carnero-González L; Hospital Universitario Araba, Vitoria, Spain., Ruiz-Salas V; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Sánchez-Sambucety P; Complejo Asistencial Universitario de León, León, Spain., López-Estebaranz JL; Hospital Universitario Fundación Alcorcón, Madrid, Spain., Gil P; Clínica Universidad de Navarra, Pamplona, Spain., Barchino L; Hospital La Zarzuela, Madrid, Spain., Arenal MM; Hospital La Paz, Madrid, Spain., Ocerin-Guerra I; Hospital Universitario de Cruces, Barakaldo, Spain., Hueso L; Hospital Manises, Valencia, Spain., Seoane-Pose MJ; Complexo Hospitalario Universitario de Santiago, Santiago Compostela, Spain., Gonzalez-Sixto B; Complejo Universitario Hospitalario Pontevedra, Pontevedra, Spain., Cano-Martinez N; Hospital La Zarzuela, Madrid, Spain.; Hospital Infanta Leonor, Madrid, Spain., Escutia-Muñoz B; Hospital Universitario La Fe, Valencia, Spain., Ortiz-Romero PL; Hospital Universitario Doce de Octubre, Madrid, Spain., Garcia-Doval I; Complexo Hospitalario Universitario de Vigo, Vigo, Spain.; Fundación Piel Sana Academia Española de Dermatología, Madrid, Spain., Descalzo MA; Fundación Piel Sana Academia Española de Dermatología, Madrid, Spain.
Jazyk: angličtina
Zdroj: International journal of dermatology [Int J Dermatol] 2020 Mar; Vol. 59 (3), pp. 321-325. Date of Electronic Publication: 2019 Nov 28.
DOI: 10.1111/ijd.14732
Abstrakt: Background: The use of Mohs micrographic surgery (MMS) for rare cutaneous tumors is poorly defined. We aim to describe the demographics, tumor presentation and topography, surgery characteristics and complications of MMS for rare cutaneous tumors in a national registry.
Methods: Prospective cohort study of patients treated with MMS in Spain between July 2013 and June 2018. The inclusion criteria were patients with cutaneous tumors with final diagnosis different from basal cell carcinoma, squamous cell carcinoma, dermatofibrosarcoma protuberans, or any kind of melanoma.
Results: Five thousand and ninety patients were recorded in the registry, from which only 73 tumors (1.4%) fulfilled the inclusion criteria: atypical fibroxanthoma (18), microcystic adnexal carcinoma (10), extramammary Paget's disease (7), Merkel cell carcinoma (5), dermatofibroma (4), trichilemmal carcinoma (4), desmoplastic trichoepithelioma (4), sebaceous carcinoma (3), leiomyosarcoma (2), porocarcinoma (2), angiosarcoma (2), trichoblastoma (1), superficial acral fibromyxoma (1), and others (10). No intra-surgery morbidity was registered. Postsurgery complications appeared in six patients (9%) and were considered mild. Median follow-up time was 0.9 years during which three Merkel cell carcinomas, one angiosarcoma, one microcystic adnexal carcinoma, and four others recurred (12.3%).
Conclusion: This national registry shows that rare cutaneous tumors represent a negligible part of the total MMS performed in our country with a low complication rate.
(© 2019 The International Society of Dermatology.)
Databáze: MEDLINE
Externí odkaz: